icon-folder.gif   Conference Reports for NATAP  
 
  ICAAC 2015 55th Interscience Conference
on Antimicrobial Agents and Chemotherapy
September 5-9, 2015, San Diego, CA
Back grey_arrow_rt.gif
 
 
 
Elvitegravir (EVG)/Cobicistat (COBI)/Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Is Superior to Ritonavir (RTV)-Boosted Atazanavir (ATV) Plus FTC/TDF in Treatment-Na´ve Women With HIV-1 Infection (WAVES Study)
 
 
  Reported by Jules Levin
ICAAC 2015 Sept 17-21 2015 San Diego, CA
 
Sally Hodder,1 Kathleen Squires,2 Joseph Gathe,3 Cissy Kityo,4 Kuanchai Supparatpinyo,5 Grigory Moshkovich,6 Monica Thorman,7 Margaret Johnson,8 Lisa Montafia,9 Shuping Jiang,9 Kirsten White,9 Javier Szwarcberg,9 Huyen Cao9
 
1West Virginia University, Morgantown, WV; 2Thomas Jefferson University Hospital, Philadelphia, PA; 3Therapeutic Concepts, Houston, TX; 4Joint Clinical Research Centre, Kampala, Uganda; 5Thai Research Institute for Health Sciences, Chiang Mai, Thailand; 6Nizhny Novgorod Regional Center AIDS, Nizhny Novgorod, Russian Federation; 7Salvador Gautier Hospital, Santo Domingo, Dominican Republic; 8Royal Free Hospital, Hampstead, UK; 9Gilead Sciences, Inc., Foster City, CA

Conclus.gif

ICAAC2.gif

ICAAC3.gif

ICAAC4.gif

ICAAC5.gif

ICAAC6.gif

ICAAC7.gif

ICAAC8.gif

ICAAC9.gif

ICAAC10.gif

ICAAC11.gif

ICAAC12.gif

ICAAC13.gif